EP3186283
COMBINATION THERAPY OF TUMOR-TARGETED IL-2 VARIANT IMMUNOCYTOKINES AND ANTIBODIES AGAINST HUMAN PD-L1
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
25.8.2015EP published:
25.12.2019EP application number:
15753700.2
EPO information:
European Patent Register
Max expiry date:
24.8.2035
Title:
COMBINATION THERAPY OF TUMOR-TARGETED IL-2 VARIANT IMMUNOCYTOKINES AND ANTIBODIES AGAINST HUMAN PD-L1
Timeline
Today
25.8.2015EP application
25.12.2019EP Publication
Owner
Name:
F. Hoffmann-La Roche AGAddress:
Grenzacherstrasse 124, 4070 Basel, CH
Inventor
Name:
UMANA, PabloAddress:
CH-8832 Wollerau, CH
Name:
KLEIN, ChristianAddress:
CH-8906 Bonstetten, CH
Name:
NICOLINI, Valeria G.Address:
CH-8703 Erlenbach/ZH, CH
Priority
Number:
14182778Date:
29.8.2014Country:
EP
Classification
Categories:
C07K 16/30, C07K 16/28, C07K 16/40, A61P 35/00, C07K 14/55, A61K 47/50